These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37291533)

  • 1. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
    Lai J; Lin X; Zheng H; Xie B; Fu D
    BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma.
    Shen F; Li F; Ma Y; Song X; Guo W
    Curr Stem Cell Res Ther; 2024; 19(3):400-416. PubMed ID: 37455452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients.
    Liu M; Zhou R; Zou W; Yang Z; Li Q; Chen Z; Jiang L; Zhang J
    Stem Cell Res Ther; 2023 Sep; 14(1):238. PubMed ID: 37674202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
    Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
    Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
    Zhang Y; Zhou J; Li H; Liu Y; Li J
    BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
    PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.
    Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R
    Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
    Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
    Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
    Zhang G
    Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering.
    Wang Y; Hou L; Yang M; Fan J; Wang Y; Sun L
    Medicine (Baltimore); 2023 Sep; 102(37):e35123. PubMed ID: 37713826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by Pseudogene OR7E47P-related Immune Genes.
    Zhao YQ; Zhang HH; Wu J; Li L; Li J; Zhong H; Jin Y; Lei TY; Zhao XY; Xu B; Song QB; He J
    Curr Med Sci; 2023 Dec; 43(6):1133-1150. PubMed ID: 38015361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Wang Y; Wan X; Du S
    Front Immunol; 2023; 14():1100100. PubMed ID: 37622118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification.
    Chen R; Gao W; Liang L; Yu H; Song W
    Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma.
    Zhang X; Xiao Q; Zhang C; Zhou Q; Xu T
    J Cell Mol Med; 2024 Apr; 28(8):e18262. PubMed ID: 38520221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.
    Wang XJ; Chen JP; Qiao XW; Meng WY; Wang YW; Meng YC; Zhao R; Lin W; Liao YD; Xiao H; Mei PY
    Curr Med Sci; 2024 Apr; 44(2):309-327. PubMed ID: 38517673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.
    Zeng L; Li L; Liao X; Zhang L; Yin C; Chen X; Sun J
    Med Oncol; 2024 Jan; 41(2):42. PubMed ID: 38170412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
    Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL
    Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
    Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.